Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Mouse Model Suggests Regulatory T Cells Play Important Role in Sjögren’s Syndrome Pathophysiology

Lara C. Pullen, PhD  |  February 5, 2018

Patients with Sjögren’s syndrome (SS) have autoreactive lymphocytes that target external glands. This autoimmune response results in impaired production of saliva and tears, and patients with SS experience xerostomia and keratoconjunctivitis sicca. Although scientists have identified both cellular and humoral immunity to exocrine tissues in patients with SS, unfortunately, our understanding of the pathophysiology of SS has remained primitive.

In general, autoimmune diseases require the presence of both autoreactive T cells and a breakdown in peripheral tolerance. This fundamental understanding of autoimmune disease has led scientists to conclude that the presence of regulatory T (Treg) cells in neonates plays an important role in the suppression of autoimmune disease, particularly in mice. Consequently, scientists in Japan have sought to better understand the role of T cells in autoimmune disease by engineering mice that lack the special genome organizing AT-rich sequence-binding protein 1 (SATB1) so that they can better understand the role of T cells in autoimmune disease.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

SATB1 is expressed in mature hematopoietic T cells, as well as dendritic cells. The SATB1 conditional knockout (SATB1cKO) mice have the SATB1 gene specifically deleted from hematopoietic cells. The mice have been described in the literature as being prone to autoimmune diseases, and they begin to die at approximately 24 weeks of age.1

New study results suggest SATB1cKO mice can be used to investigate the progression and characteristics of SS, providing an important experimental tool. Yuriko Tanaka, PhD, assistant professor at the Toho University School of Medicine in Japan, and colleagues reported that SATB1cKO mice develop major CD4+ T cell infiltrates shortly after weaning, approximately four weeks after birth. The SATB1cKO mice also exhibited a Treg deficiency during the first week after birth. The investigators published their results online Nov. 10, 2017, in the Journal of Immunology.2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“We recently demonstrated that SATB1 is indispensable for the development of thymic Treg cells, but not for the differentiation of peripheral Treg (pTreg) cells,” write the authors in their discussion. “Therefore, the Treg cells in the periphery of SATB1cKO mice are mostly pTreg cells. Because Treg cells derived from SATB1cKO mice suppressed the development of SS in SATB1cKO mice to a degree similar to that of Treg cells from WT [wild type] mice, it is highly possible that both thymic Treg and pTreg cells present a similar suppressive function against activation of T cells involved in the pathogenesis of autoimmune diseases.”

Specifically, the investigators reported that, at four weeks of age, the SATb1cKO mice had significantly decreased saliva production relative to WT littermates. When the researchers examined the types of lymphocytes infiltrating the glands of the SATB1cKO mice, they found the mice developed a T cell-dominant immune cell infiltration at four weeks. However, the frequency of B cells gradually increased over time. Likewise, the levels of anti-SSA and anti-SSB antibodies increased at approximately 8 weeks of age, a time that coincided with the lowest level of salivary production.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsSjögren’s Disease Tagged with:pathophysiologyregulatory T cellsSjogren's

Related Articles

    Treg Cells May Orchestrate Muscle Repair after Injury

    May 30, 2014

    New research shows the accumulation of regulatory T cells in damaged muscle corresponds with a switch in the myeloid cell infiltrate from a proinflammatory to a proregenerative phenotype.

    2014 ACR/ARHP Annual Meeting: Regulatory T Cells

    April 1, 2015

    Rheumatology experts explore ways Treg cells contribute to autoimmune diseases, RA

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

    Protein Phosphatase 2A and Regulatory T Cell Function Researched

    June 13, 2016

    The serine-threonine protein phosphatase 2A (PP2A) enzyme is critical for regulatory T cells to function—without it, they don’t have the ability to suppress effector T cells and can’t protect against autoimmunity, according to new research published in Nature Immunology. Researchers found that conditional knockout mice—in which PP2A expression is knocked out only in regulatory T cells—developed…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences